📌 Key Takeaways
- Topic: What Is Silica D50? How Median Particle Size Is Measured and Why It Matters
- Keywords: silicone
- Published: 2026-11-20 13:09:06
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Kaolin vs Silica: Filler Properties, Uses and Selection Guide
- How to Buy Silica Powder: Grade Selection, Supplier Checks and Ordering Tips
- Cai, C. et al. Polydopamine-coated gold core/hollow mesoporous silica shell particles as a nanoplatform for multimode imaging and photothermal therapy of tumors. Chem. Eng. J. 362, 842-850 (2019). Article CAS Google Scholar
- Silica as a Thickening Agent: How It Works in Liquids, Resins and Gels
- Biswas, R. et al. Vanadium‐Incorporated Mesoporous Silica as Oxidase Mimic for Colorimetric Dopamine Detection and Anticancer Activity. ChemistrySelect 8, e202204989 (2023). Article CAS Google Scholar
- What Is Micro Silica? Properties, Specifications and Uses in Concrete and Refractories
- Li, D., Müller, M. B., Gilje, S., Kaner, R. B. & Wallace, G. G. Processable aqueous dispersions of graphene nanosheets. Nat. Nanotechnol. 3, 101-105 (2008). Piece CAS PubMed Google Scholar
- Solvay Zeosil: Highly Dispersible Silica Grades for Tires and Rubber
- Shi, M. et al. Stimulation of osteogenesis and angiogenesis of hBMSCs by delivering Si ions and functional drug from mesoporous silica nanospheres. Acta Biomater. 21, 178-189 (2015). Piece CAS PubMed Google Scholar
Transparent Silica Filler: How to Keep Clarity in Coatings and Resins
What is silica (SiO₂)?
silica Mohs hardness Gao, J. et al. PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to raised tumor site drug accumulation and reduced tumor burden. Eur. J. Pharm. Sci. 140, 105070 (2019). Post CAS PubMed Google Scholar
What is the difference between fumed silica and precipitated silica?
silica manufacturer India Chambers, H. F. & DeLeo, F. R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629-641 (2009). Article CAS PubMed Central PubMed Google Scholar
What drives silica raw material prices?
The complexity and heterogeneity of the illness microenvironment brings about the problem of poor therapeutic efficiency of single therapies. 465, 466, 467, 468, 469 The current clinical research trend has steadily shifted to multimodal synergistic therapy, as we have noted above with many examples of multimodal synergistic therapy platform construction. In multimodal synergistic therapy, the interaction between different treatment modalities can substantially boost the shortcomings of single therapy, such as overcoming the lack of light penetration depth in PDT, lowering the toxic side effects of chemotherapy, etc., and producing stronger therapeutic outcome through superimposed impacts (namely "1 + 1 > 2"). 470, 471, 472 A prominent feature of multimodal synergistic therapies is the skill to effectively overcome multidrug resistance in diseases, and MSNs are uniquely advantageous in integrating these aforementioned treatment modalities. 369, 473, 474, 475 As an illustration, most of the multidrug resistance generated during chemotherapy of malignant tumors might stem from the overexpression of transmembrane ATP-binding cassette transporter and transmembrane Ca 2+ channels. 476, 477 To address this problem, researchers used mesoporous silica nanocapsules to encapsulate and deliver the cytotoxic drug DOX and T-type Ca 2+ channel siRNA. 478 On the one hand, MSNs can bypass the drug efflux pumps and enter cells directly through endocytosis, increasing the intracellular accumulation of drugs. On the other hand, siRNA can knock down the T-type Ca 2+ channel, leading to a decrease in cytosol Ca 2+ concentration in the cytosol, thus increasing the sensitivity of tumor cells to DOX. Accordingly, the as-designed MSNs-based therapeutic system attained effective chemotherapy-gene therapy to overcome the multidrug resistance in breast cancer. 478 Besides, drug-resistant bacterial infections are a current thorny public health issue. 479 In this regard, researchers have developed a photodynamic combined lysozyme antimicrobial therapy based on upconversion NPs/MSNs nanocomposites to combat the problem of drug-resistant bacterial infections in deep tissues. Briefly, upconversion NPs were sequentially encapsulated with hierarchical coating of dense silica and dendritic mesoporous silica, followed by loading photosensitizers and lysozyme, and finally modified with bacterial hyaluronidase-response valves on the MSNs surface to accomplish controllable release of lysozyme. The results demonstrated that this system promoted direct attack of ROS on cell membranes and cytoplasm through enzymatic cell wall disassembly, resulting in an excellent bactericidal rate toward methicillin-resistant Staphylococcus aureus (> 5 log10 viability reduction). 480
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.